Immediate Impact

1 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
2022 Standout
7 intermediate papers

Works of Tilmann Schumacher being referenced

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study
2002
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
2002
and 1 more

Author Peers

Author Last Decade Papers Cites
Tilmann Schumacher 354 428 268 6 591
Miklos Pless 325 353 302 7 546
Boris Warwitz 215 255 257 13 516
Ch. Bruns 278 408 206 7 671
Giancarlo Montini 271 271 270 7 518
Marianne E. Pavel 454 542 355 11 718
L Ausema 275 376 242 8 550
Jan-Paul Esser 478 595 413 6 738
E. Weckesser 223 276 242 9 638
Josef Doll 190 271 128 13 728
Chiara Grana 309 273 200 8 679

All Works

Loading papers...

Rankless by CCL
2026